-
Sort By
-
Newest
-
Newest
-
Oldest
It was another busy day as reporting season ramped up, the ASX 200 (ASX:XJO) finishing 0.5% higher as signs of slowing Victorian COVID-19 cases boosted National Australia Bank Ltd (ASX:NAB), rising 2.4%.
The gold price is soaring, all thanks to a world gripped by fear, or is it hope?
The ASX 200 (ASX:XJO) hit a three week high to start the week, adding 1.8% as slowing Victorian Coronavirus case numbers boost confidence.
The ASX 200 (XJO:ASX) finished another 0.7% higher with BHP Group Ltd (ASX:BHP) contributing close to 40% of the gain alone, after rallying another 4.9% as iron ore prices hit USD$114 per tonne.
The ASX 200 (XJO:ASX) finished down another 0.7% on Wednesday, pushed lower by healthcare (-1.7%), industrials (-1.5%) and consumer staples (-1.2%).
In the first of a series on Australian biotech success stories, we start with some of the outstanding medical device stocks on the ASX.
The ASX 200 (XJO:ASX) managed to fight off the widespread implications of Victoria’s ‘State of Disaster’ announcement, finishing flat for the delay despite nearly all businesses now being forced to close down.
The South China Sea conflict has largely been a case of ‘failure to act’ whilst the law of the sea has been flouted. China continues to exert military control over its neighbours over the hotly contested waterways, completely unabated.
Wednesday proved to be another wild day for markets with Australia’s ASX 200 index down over 1% at the open, only to rally 2% and finally finish 5 points down as the session ended.
In the USA, it was Memorial Day. However, a strong lead from the local futures market was enough to send the ASX 200 to an 11-week high on Monday, but over 2% for the day.
Most of us have not experienced the current level of government and institutional direction of our lives. The impact on business is likely to be profound.
The third quarter capped the best year-to-date return for the Bloomberg Barclays US Aggregate Bond Index since the first nine months of 2002. Although bond prices may continue to advance, we anticipate lower returns may accompany a rise in volatility in coming quarters.
